“The increase in Social Anxiety Disorder market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM”
The Social Anxiety Disorder market report provides current treatment practices, emerging drugs, Social Anxiety Disorder market share of the individual therapies, and current and forecasted Social Anxiety Disorder Market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Social Anxiety Disorder treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of opportunities and assesses the underlying potential of the Social Anxiety Disorder market.
Key highlights from Social Anxiety Disorder Market Report
§ The Social Anxiety Disorder market size is anticipated to increase during the study period, 2019–2032
§ According to the analysis, females are more frequently diagnosed with SAD compared to males.
§ According to the National Institute of Health and Care Excellence (NICE), the lifetime prevalence of Social Anxiety disorder is 12% in UK population.
§ Social Anxiety Disorder Market Companies included Vistagen Therapeutics, Bionomics, and several others
§ Social Anxiety Disorder Market Therapies included PH94B, BNC210, and several others
Download a PDF Sample Copy of the Social Anxiety Disorder Market Research Report- Social Anxiety Disorder Market Share
Social Anxiety Disorder Overview
Social Anxiety disorder (SAD), also called Social Phobia, is the most common mental health condition which causes extreme fear in social settings, and an intense, persistent fear of being watched and judged by others. Social Anxiety disorder symptoms may include physical symptoms which can be blushing, nausea, excessive sweating, trembling or shaking, difficulty in speaking, dizziness or lightheadedness, and rapid heart rate.
Social Anxiety Disorder Epidemiology Segmentation in the 7MM
- Social Anxiety disorder total Prevalent Cases
- Social Anxiety disorder Severity Specific Cases
- Social Anxiety disorder Total Treated Cases
- Social Anxiety disorder Age- Specific Prevalence
- Social Anxiety disorder Total Diagnosed Cases
Social Anxiety Disorder Treatment Market
For social anxiety disorder, the treatment includes psychological and pharmacological options. The psychological intervention termed cognitive-behavioral therapy (CBT) is used to help patients face barriers directly through exposure techniques, relaxation techniques, and training in social and conversational skills. It is always recommended that CBT should be always implemented ahead of pharmacologic therapy. Patients who manage their symptoms with psychological and pharmacologic treatment are more likely to achieve continued symptom-improvement benefits. SAD is typically treated on a long-term basis using FDA-approved antidepressants with a sluggish onset of action (weeks) and limited therapeutic effects, as well as benzodiazepines, which are not FDA-approved for the treatment of SAD but are recommended for off-label usage.
Get to know more information about the Social Anxiety Disorder Market Outlook and Companies- Social Anxiety Disorder Market Size
“Among adults, social anxiety disorder is particularly likely to occur alongside other anxiety disorders (up to 70%), followed by any affective disorder (up to 65%), nicotine dependence (27%), and substance-use disorder (about 20%)”
Social Anxiety Disorder Market Dynamics
The Social Anxiety Disorder Market Dynamics market is anticipated to change in the coming years owing to the improvement in the research and development undertaking. Major Pharma giants are thoroughly working toward the development of new treatment therapies for this indication, in order to provide better relief for the symptoms and hence improve the Quality of life (QoL) of patients with SAD.
SSRIs are first-line agents for the treatment of SAD and it works by elevating the patient’s serotonin level, ultimately leading to regulated mood and improved mental well-being. It may take up to 6 weeks to see symptom improvement with SSRIs. Some patients may experience anxiety or jitteriness during the first 2 weeks of therapy. Historically, SSRIs are the most widely used antidepressant class owing to more tolerable and shorter-lasting AEs than other classes.
Scope of the Social Anxiety Disorder Market Report
- Coverage- 7MM
- Study Period- 2019-2032
- Forecast Period- 11 Years
- Social Anxiety Disorder Market Companies included- Vistagen Therapeutics, Bionomics, and several others
- Social Anxiety Disorder Market Therapies included PH94B, BNC210, and several others
- Market Drivers and Barriers
- KOL Views
- Market Access and Reimbursement
Know more facts about the Social Anxiety Disorder Market Size of the report, view here- Social Anxiety Disorder Market Forecast
Table of Content
1. Key Insights
2. Social Anxiety Disorder Executive Summary
3. Competitive Intelligence Analysis for Social Anxiety Disorder
4. Social Anxiety Disorder Market Overview at a Glance
5. Social Anxiety Disorder Market Disease Background and Overview
6. Patient Journey
7. Social Anxiety Disorder Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Social Anxiety Disorder Unmet Needs
10. Key Endpoints of Social Anxiety Disorder Treatment
11. Social Anxiety Disorder Marketed Products
12. Social Anxiety Disorder Emerging Therapies
13. Social Anxiety Disorder Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Social Anxiety Disorder Market Outlook
16. Access and Reimbursement Overview of Social Anxiety Disorder
17. KOL Views
18. Social Anxiety Disorder Market Drivers
19. Social Anxiety Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Got Queries? For in-depth information on the Social Anxiety Disorder Market Forecast Report @ Social Anxiety Disorder Market Trend
Get More Information on Highly Demanded Market Research Reports
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
